FDA's Doran Fink: "I know there is intense interest in the potential for using this vaccine as a booster dose...We don't have the capacity to discuss that today."
— Anjalee Khemlani (@AnjKhem) June 7, 2022
Adds: would evaluate study data to inform the safety/effectiveness of a booster dose as it comes.